BioLineRx (BLRX) Receivables - Other (2010 - 2025)
BioLineRx's (BLRX) quarterly Receivables - Other came in at $410000.0 in Q4 2025, down 72.26% year-on-year from $1.5 million in Q4 2024, and down 41.34% quarter-over-quarter from $699000.0 in Q3 2025.
BioLineRx (BLRX) Receivables - Other (2010 - 2025) Analysis & Trends
BioLineRx's Receivables - Other history runs 16 years deep, the most recent figure standing at $410000.0 for Q4 2025.
- On a quarterly basis, Receivables - Other fell 72.26% year-over-year to $410000.0 in Q4 2025; TTM through Dec 2025 was $410000.0, a 72.26% decrease from a year earlier, with the FY2025 full-year figure at $410000.0, down 72.26% from the prior year.
- Receivables - Other slipped to $410000.0 in Q4 2025 per BLRX's latest filing, from $699000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $1.5 million in Q4 2024 and bottomed at $128000.0 in Q2 2023.
- The 5-year median for Receivables - Other is $332500.0 (2023), against an average of $440800.0.
- Across the five-year window, Receivables - Other jumped 412.5% in 2024 and plunged 72.26% in 2025, its largest moves.
- Year by year, Receivables - Other stood at $142000.0 in 2021, then jumped by 407.75% to $721000.0 in 2022, then rose by 15.12% to $830000.0 in 2023, then surged by 78.07% to $1.5 million in 2024, then plunged by 72.26% to $410000.0 in 2025.
- Per Business Quant, the three latest BLRX Receivables - Other figures stand at $410000.0 (Q4 2025), $699000.0 (Q3 2025), and $203000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 410,000.00 |
| Dec 31, 2025 | 410,000.00 |
| Sep 30, 2025 | 699,000.00 |
| Sep 30, 2025 | 699,000.00 |
| Jun 30, 2025 | 203,000.00 |
| Jun 30, 2025 | 203,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Dec 31, 2024 | 1.48 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 350,000.00 |
| Sep 30, 2024 | 350,000.00 |
| Jun 30, 2024 | 656,000.00 |
| Jun 30, 2024 | 656,000.00 |
| Mar 31, 2024 | 507,000.00 |
| Mar 31, 2024 | 507,000.00 |
| Dec 31, 2023 | 830,000.00 |
| Dec 31, 2023 | 830,000.00 |
| Sep 30, 2023 | 315,000.00 |
| Sep 30, 2023 | 315,000.00 |